Press release
Cancer Biomarker Testing Market is expected to reach US$ 96.53 Billion by 2033 | Major players - Illumina, Inc., F. Hoffmann-La Roche Ltd, Abbott, QIAGEN.
Cancer Biomarker Testing Market
The Global Cancer Biomarker Testing Market size reached US$ 33.37 Billion in 2024 and is expected to reach US$ 96.53 Billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.
The Cancer Biomarker Testing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/cancer-biomarker-testing-market?sz
The Cancer Biomarker Testing Market refers to the industry focused on identifying, analyzing, and validating biological markers to detect cancer, predict disease progression, and guide personalized treatment. It includes molecular, genetic, and protein-based tests used in diagnostics, drug development, prognosis assessment, and therapy selection across hospitals, laboratories, and research settings.
Recent Key Developments of United States:
✅ November 2025: FDA approved pembrolizumab formulations and companion diagnostics alongside oncology therapies, boosting biomarker-driven precision care in solid tumors.
Approvals included tools for HER2, EGFR, and other mutations, enhancing access to targeted treatments.
✅ October 2025: Mainz Biomed reported topline results from a feasibility study on a blood-based biomarker panel for early pancreatic cancer detection, achieving 100% sensitivity and 95% specificity.
The study advances non-invasive screening for pancreatic neoplasms using optimized biomarkers.
✅ September 2025: Exact Sciences launched Cancerguard, the first commercially available multi-cancer early detection blood test analyzing multiple biomarker classes for a wide range of cancers.
This laboratory-developed test supports early diagnosis of hard-to-detect cancers using diverse biomarkers.
Recent Key Developments of Europe:
✅ November 2025: Cancer and tumor biomarker-based assay market reports highlighted Europe's growth in genomic profiling and liquid biopsies, driven by Germany, UK, and France.
Trends include AI-enhanced analytics and multi-biomarker panels for precision diagnostics.
✅ October 2025: Q3 EMA approvals featured companion diagnostics for rare brain tumors and NSCLC, including EGFR and HER2 tests integrated with new agents.
These decisions support biomarker-stratified therapies in advanced oncology settings.
✅ September 2025: EMA approved pembrolizumab subcutaneous formulation (Keytruda Qlex) for tumor mutational burden-high solid tumors, tied to biomarker testing.
This expands precision medicine options requiring companion diagnostics across multiple cancers.
List of the Key Players in the Cancer Biomarker Testing Market:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Abbott
QIAGEN
Siemens Healthineers AG
Bio-Rad Laboratories, Inc
Agilent Technologies
BioMérieux
Foundation Medicine, Inc.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-biomarker-testing-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Cancer Biomarker Testing Market:
By Biomarker Type: Genetic Biomarkers, Protein Biomarkers, Others.
By Technology: Omics Technologies, Imaging Technologies, Immunoassays, Next-Generation Sequencing (NGS), PCR-based Techniques, Others.
By Product Type: Instruments, Consumables, Software.
By Application: Diagnostics, Drug Discovery and Development, Therapy Prediction and Monitoring, Personalized and Precision Medicine, Others.
By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Liver Cancer, Melanoma, Blood Cancers, Others.
By End-User: Hospitals, Diagnostic Laboratories, Biopharmaceutical and Biotechnology Companies, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=cancer-biomarker-testing-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cancer Biomarker Testing market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Cancer Biomarker Testing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Cancer Biomarker Testing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cancer Biomarker Testing Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Cancer Biomarker Testing Market in 2025?
◆ What is the projected growth rate of the Cancer Biomarker Testing Market through 2033?
◆ Who are the key players in the Cancer Biomarker Testing Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarker Testing Market is expected to reach US$ 96.53 Billion by 2033 | Major players - Illumina, Inc., F. Hoffmann-La Roche Ltd, Abbott, QIAGEN. here
News-ID: 4327618 • Views: …
More Releases from DataM Intelligence 4Market Research
Air Ambulance Market is expected to reach US$ 44.37 billion by 2033 | Major Comp …
Market Size and Growth:
The Global Air Ambulance Market size reached US$ 16.59 billion in 2024 and is expected to reach US$ 44.37 billion by 2033, growing at a CAGR of 10.2% during the forecast period 2025-2033.
The Air Ambulance Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
Mucopolysaccharidoses Market is expected to reach US$ 4,389.85 million by 2033 | …
Market Size and Growth:
The Global Mucopolysaccharidoses Market size reached US$ 2,313.08 million in 2024 and is expected to reach US$ 4,389.85 million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
The Mucopolysaccharidoses Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and…
Battery as a Service Market is expected to reach US$ 11.20 billion by 2032 | Maj …
Market Size and Growth:
The Global Battery as a Service Market size reached US$ 1.71 billion in 2024 and is expected to reach US$ 11.20 billion by 2032, growing with a CAGR of 26.50% during the forecast period 2025-2032.
The Battery as a Service Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers…
Vitamins and Minerals Market is expected to reach US$ 34.59 billion by 2032 | To …
Market Size and Growth:
The Global Vitamins and Minerals Market size reached US$ 22.68 billion in 2024 and is expected to reach US$ 34.59 billion by 2032, growing with a CAGR of 5.42% during the forecast period 2025-2032.
The Vitamins and Minerals Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
